MX9203692A - Preparaciones terapeuticas. - Google Patents
Preparaciones terapeuticas.Info
- Publication number
- MX9203692A MX9203692A MX9203692A MX9203692A MX9203692A MX 9203692 A MX9203692 A MX 9203692A MX 9203692 A MX9203692 A MX 9203692A MX 9203692 A MX9203692 A MX 9203692A MX 9203692 A MX9203692 A MX 9203692A
- Authority
- MX
- Mexico
- Prior art keywords
- quinazoline derivatives
- new
- trifluoromethyl
- nitro
- alkyl
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 108010002164 tyrosine receptor Proteins 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a composiciones farmacéuticas que comprenden derivados de quinazolina nuevos o conocidos de la fórmula I: (fórmula); en donde por ejemplo, R1 es hidrógeno, trifluorometilo o nitro, n es 1 y R2 halógeno, trifluorometilo, nitro, ciano, (1-4C) alquilo, (1-4C)alcoxi, N-(1-4C)alquilamino,N,N-di-((1-4C)alquil)amino, (1-4C)alquiltio, (1-4C)alquilsulfinilo o (1-4C) alquilsulfonilo; y diluyentes farmacéuticamente aceptables o portadores de los mismos; los nuevos derivados de quinazolina y a un procedimiento para su preparación; y el uso de las propiedades inhibitorias del receptor quinasa tirosina tanto de los derivados de quinazolina conocidos como de los nuevos en el tratamiento del cáncer.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919113970A GB9113970D0 (en) | 1991-06-28 | 1991-06-28 | Therapeutic preparations |
| GB929201133A GB9201133D0 (en) | 1992-01-20 | 1992-01-20 | Therapeutic preparations |
| GB929213181A GB9213181D0 (en) | 1991-06-28 | 1992-06-22 | Therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9203692A true MX9203692A (es) | 1994-07-29 |
Family
ID=27265736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9203692A MX9203692A (es) | 1991-06-28 | 1992-06-29 | Preparaciones terapeuticas. |
Country Status (1)
| Country | Link |
|---|---|
| MX (1) | MX9203692A (es) |
-
1992
- 1992-06-29 MX MX9203692A patent/MX9203692A/es not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO922517D0 (no) | Terapeutiske preparater | |
| ATE63742T1 (de) | Chinazolinon-derivate. | |
| ATE152443T1 (de) | Anilide-derivate | |
| AR007857A1 (es) | Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios uso en medicina ycomposiciones farmaceuticas que los contienen. | |
| NO983707L (no) | Kinazolin-derivater som antitumor-midler | |
| ES2191187T3 (es) | Compuestos heteroaromaticos biciclicos como inhibidores de la proteina tirosin-quinasa. | |
| ES2171884T3 (es) | Compuestos de quinazolina. | |
| BR0215312A (pt) | Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto | |
| FI970968A0 (fi) | Pyrimido/5,4-d/pyrimidiinit, näitä yhdisteitä sisältävät lääkeaineet, niiden käyttö ja menetelmä niiden valmistamiseksi | |
| ES2167377T3 (es) | Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos. | |
| ES2078798T3 (es) | Derivados de quinazolina. | |
| BR0009041A (pt) | Derivado de amida, processo para a preparação deum derivado de amida, composição farmacêutica,uso de um derivado de amida, e, método paratratar doenças ou quadros clìnicos mediados porcitocinas | |
| BR0312648A (pt) | Processo para preparação de certos compostos pirrolo triazina | |
| TR199901433T2 (xx) | Pirolo$3,4-D] pirimidinon t�revleri ve bunlar�n ila� olarak kullan�mlar�. | |
| ES2108717T3 (es) | Derivados de la tetrahidropirrolo(1,2-a)pirazina-4-espiro-3'-pirrolidina, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| BR0308145A (pt) | Composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto | |
| ES2059534T3 (es) | Nuevos derivados benzopiranos antihipertensivos. | |
| ES2175405T3 (es) | Derivados de adenosina. | |
| MX9203692A (es) | Preparaciones terapeuticas. | |
| ES2049659A1 (es) | Una composicion farmaceutica a base de derivados de quinazolina con actividad anti-cancerigena. | |
| MX9300277A (es) | Derivados de quinazolina. | |
| MX9306034A (es) | Derivados de quinazolina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |